Benitec Biopharma Inc. (BNTC)
About Benitec Biopharma Inc.
Benitec Biopharma Inc is a clinical-stage biotechnology company focused on the advancement of novel genetic medicines. Its technology has the potential to provide a one-shot cure for a wide range of diseases that are addressed by strict ongoing treatment regimens or that have no effective treatment or only palliative care options. The Company is developing a silence and replace-based therapeutic (BB-301) for the treatment of Oculopharyngeal Muscular Dystrophy (OPMD), a chronic, life threatening genetic disorder.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2021
- $59.0K
- Net income
- -$37.9M
- Total assets
- $99.6M
- Market cap
- $362.4M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Revenue
- $0
- Operating expenses
- $41.8M
- Operating income
- -$41.8M
- Net income
- -$37.9M
- EPS (basic)
- $-1.05
- EPS (diluted)
- $-1.05
Balance sheet
- Total assets
- $99.6M
- Current assets
- $98.5M
- Total liabilities
- $2.3M
- Current liabilities
- $1.8M
- Shareholders’ equity
- $97.3M
Cash flow
- Operating cash flow
- -$23.6M
- Investing cash flow
- -$18.0K
- Financing cash flow
- $70.5M
- Net cash flow
- $46.9M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $362.4M
- EPS (diluted)
- $-1.05
- Shares outstanding
- 31.6M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Jul 11, 2012
Benitec Biopharma Inc. (BNTC) Stock Price
- Reported a net loss of $37.9M in FY2021.
- Trading 31% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Benitec Biopharma Inc..
Write a review
News about Benitec Biopharma Inc.
News & sentiment via Polygon.io
Benitec Biopharma Inc.: frequently asked questions
Is Benitec Biopharma Inc. an American company?
Benitec Biopharma Inc. is a US-based company headquartered in Hayward, California, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Benitec Biopharma Inc. headquartered?
Benitec Biopharma Inc. is headquartered in Hayward, California, United States.
Is Benitec Biopharma Inc. publicly traded?
Yes — Benitec Biopharma Inc. is a publicly traded company. Its stock trades under the ticker symbol BNTC on the NASDAQ.
What does Benitec Biopharma Inc. do?
Benitec Biopharma Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
